Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti–malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic. The company also provides formulations, including antibiotics, antibacterial, anti-platelet, laxative, anti-ulcer, enzymes, anti-asthmatic, anti-malarial, anti-cold, anti-allergic, anti-viral, anti-psychotic, anti-fungal, vitamins, topical steroids, corticosteroids, anti-inflammatory, analgesic, anti-pyretic, anti-diabetic, cardiac, and other products. In addition, it offers disposable surgical and casting tape products; herbal products; veterinary products; nutraceutical products; and oncology products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.
Metrics to compare | VAIH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVAIHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −166.9x | 21.4x | −0.5x | |
PEG Ratio | 0.64 | 0.02 | 0.00 | |
Price/Book | 1.3x | 2.4x | 2.6x | |
Price / LTM Sales | 0.7x | 2.2x | 3.2x | |
Upside (Analyst Target) | - | 35.8% | 50.1% | |
Fair Value Upside | Unlock | 9.8% | 6.5% | Unlock |